Conference addressed clinical research, biomedical statistics, and preclinical studies, highlighting future directions.
On April 24-25, 2025, the XII All-Russian Conference with international participation «Topical issues of preclinical and clinical studies of drugs and clinical trials of medical devices» was organized and held. The topic of the conference brought together leading experts in the field of preclinical and clinical research. Participants’ prospects for the development of toxicology, preclinical studies of specific activity and translational models, programs for the preclinical development of biomedical cell products, experience in the clinical application of medical programs using artificial intelligence, a personalized approach to prevention and therapy in psychiatry and narcology, pharmacovigilance, the use of real clinical practice data, regulatory issues of clinical trials in pediatrics, data management, biomedical statistics, and mathematical modeling in preclinical and clinical studies. Following the conference, a Resolution was developed, the text of which we invite you to familiarize yourself with.
No takes yet. Share an insight, caveat, or question.
Zvartau et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: